| Application no. and date | 04001441.7 (espacenet) (Federated) (European Patent Register), 20000516 | | Patent/reg. no. and date | DK/EP 1410800, 20060823 | | Publication date | 20040421 | | Priority no. and date | EP 99109295, 19990527 | | EP pub. no. and date |
EP 1410800 20040421 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P41380DK01 | | Inventor | VAN AMSTERDAM, Christoph, Schepp Allee 47
64295 Darmstadt, DE,
BARTOSZYK, Gerd, Kreuzstrasse 57
64331 Weiterstadt, DE,
SEYFRIED, Christoph, Mathildenstrasse 6
64342 Seeheim-Jugenheim, DE,
Boettcher, Henning, Stiftstrasse 12
64287 Darmstadt, DE,
Sedman, Ewen, The Barley House Dene Lea Ropley
Alresford, Hamshire SO24 0BH, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/495 (2006.01) | | Title | Anvendelse af 1-[4-(5-cyanoindol-3-yl)butyl]-4(2-carbamoyl-benzofuran-5-yl)-piperazin og de fysiologisk acceptable salte deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
